Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Dechra Pharmaceuticals Plc LSE:DPH London Ordinary Share GB0009633180 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -40.00 -1.18% 3,350.00 3,360.00 3,364.00 3,450.00 3,352.00 3,450.00 158,267 16:35:02
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 515.1 40.9 32.9 101.9 3,621

Dechra Pharmaceuticals PLC Director/PDMR Shareholding

02/10/2020 9:04am

UK Regulatory (RNS & others)


Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart


From Sep 2020 to Nov 2020

Click Here for more Dechra Pharmaceuticals Charts.

TIDMDPH

RNS Number : 9431A

Dechra Pharmaceuticals PLC

02 October 2020

2 October 2020

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Dechra Pharmaceuticals PLC announces that on 1 October 2020, Paul Sandland, Executive Director and PDMR exercised approved and unapproved options over ordinary shares of 1p each in the Company. The options were granted under the Dechra Pharmaceuticals Approved Option Scheme and Dechra Pharmaceuticals Unapproved Option Scheme as detailed below. The exercise of the options was subject to the achievement of performance conditions which were satisfied to the extent that the options vested at 100%. Paul Sandland sold 2,474 of the shares acquired, and retained the remaining 1,449 shares.

 
 Date of         Scheme       Number of   Option Price  Number of shares   Sale 
  Grant                        options                   sold               Price 
                               exercised 
 15 September    Approved     923         GBP9.75       Nil                N/A 
  2015 
 19 September    Approved     526         GBP13.69      Nil                N/A 
  2016 
 19 September 
  2016           Unapproved   2,474       GBP13.69      2,474              GBP32.23 
 

Paul Sandland's total beneficial holding following these transactions is 6,518 ordinary shares which represents 0.006% of the total issued share capital.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Forms

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                  Paul Sandland 
     ------------------------------------  ------------------------------------------ 
 2.   Reason for the notification 
     -------------------------------------------------------------------------------- 
 a)   Position/status                       Director/PDMR 
     ------------------------------------  ------------------------------------------ 
 b)   Initial notification/                 Initial Notification 
       amendment 
     ------------------------------------  ------------------------------------------ 
 3.   Details of the Issuer 
     -------------------------------------------------------------------------------- 
 a)   Name                                  Dechra Pharmaceuticals PLC 
     ------------------------------------  ------------------------------------------ 
 b)   LEI code                              213800J4UVB5OWG8VX82 
     ------------------------------------  ------------------------------------------ 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     -------------------------------------------------------------------------------- 
 a)   Description of                        Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                             ISIN: GB0009633180 
       Identification 
       code 
     ------------------------------------  ------------------------------------------ 
 b)   Nature of the                         Exercise of options under the Company's 
       transaction                           Approved Option Scheme 
     ------------------------------------  ------------------------------------------ 
 c)   Price(s) and volumes(s)               Price(s)              Volume(s) 
                                             GBP9.75               923 
                                             GBP13.69              526 
     ------------------------------------  --------------------  -------------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                              1,449 
                                              GBP11.18 
             *    Price                       GBP16,200.19 
 
 
             *    Total 
     ------------------------------------  ------------------------------------------ 
 e)   Date of the transaction               2020.10.01 
     ------------------------------------  ------------------------------------------ 
 f)   Place of the transaction              Outside a trading venue 
     ------------------------------------  ------------------------------------------ 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                  Paul Sandland 
     ------------------------------------  ------------------------------------------ 
 2.   Reason for the notification 
     -------------------------------------------------------------------------------- 
 a)   Position/status                       Director/PDMR 
     ------------------------------------  ------------------------------------------ 
 b)   Initial notification/                 Initial Notification 
       amendment 
     ------------------------------------  ------------------------------------------ 
 3.   Details of the Issuer 
     -------------------------------------------------------------------------------- 
 a)   Name                                  Dechra Pharmaceuticals PLC 
     ------------------------------------  ------------------------------------------ 
 b)   LEI code                              213800J4UVB5OWG8VX82 
     ------------------------------------  ------------------------------------------ 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     -------------------------------------------------------------------------------- 
 a)   Description of                        Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                             ISIN: GB0009633180 
       Identification 
       code 
     ------------------------------------  ------------------------------------------ 
 b)   Nature of the                         Exercise of options under the Company's 
       transaction                           Unapproved Option Scheme 
     ------------------------------------  ------------------------------------------ 
 c)   Price(s) and volumes(s)               Price(s)              Volume(s) 
                                             GBP13.69              2,474 
     ------------------------------------  --------------------  -------------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                              2,474 
                                              GBP13.69 
             *    Price 
                                              GBP33,869.06 
 
             *    Total 
     ------------------------------------  ------------------------------------------ 
 e)   Date of the transaction               2020.10.01 
     ------------------------------------  ------------------------------------------ 
 f)   Place of the transaction              Outside a trading venue 
     ------------------------------------  ------------------------------------------ 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                 Paul Sandland 
     -----------------------------------  ---------------------------------------------- 
 2.   Reason for the notification 
     ----------------------------------------------------------------------------------- 
 a)   Position/status                      Director/PDMR 
     -----------------------------------  ---------------------------------------------- 
 b)   Initial notification/                Initial Notification 
       amendment 
     -----------------------------------  ---------------------------------------------- 
 3.   Details of the Issuer 
     ----------------------------------------------------------------------------------- 
 a)   Name                                 Dechra Pharmaceuticals PLC 
     -----------------------------------  ---------------------------------------------- 
 b)   LEI code                             213800J4UVB5OWG8VX82 
     -----------------------------------  ---------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ----------------------------------------------------------------------------------- 
 a)   Description of                       Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                            ISIN: GB0009633180 
       Identification 
       code 
     -----------------------------------  ---------------------------------------------- 
 b)   Nature of the                        Sale of shares obtained under the Company's 
       transaction                          Unapproved Share Option Scheme 
     -----------------------------------  ---------------------------------------------- 
 c)   Price(s) and volumes(s)              Price(s)                 Volume(s) 
                                            GBP 32.23                2,474 
     -----------------------------------  -----------------------  --------------------- 
 d)        Aggregated information 
             *    Aggregate volume           2,474 
 
                                             GBP 32.23 
             *    Price                      GBP79,737.02 
 
 
             *    Total 
     -----------------------------------  ---------------------------------------------- 
 e)   Date of the transaction              2020.10.01 
     -----------------------------------  ---------------------------------------------- 
 f)   Place of the transaction             London Stock Exchange 
     -----------------------------------  ---------------------------------------------- 
 

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHKKBBKFBDKBKK

(END) Dow Jones Newswires

October 02, 2020 04:04 ET (08:04 GMT)

1 Year Dechra Pharmaceuticals Chart

1 Year Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart
ADVFN Advertorial
Your Recent History
LSE
DPH
Dechra Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201123 20:09:13